EPA Adopts Two Non-Animal Methods for Chemical Safety Reviews
The Environmental Protection Agency announced August 27, 2026, that it had adopted two scientific approaches intended to reduce animal testing in reviews of certain new chemicals and pesticide formulations.
The actions address different parts of chemical safety review. One is an interim framework using three-dimensional human airway tissue and digital modeling to assess respiratory irritation from certain surfactants. The other is the internationally recognized Globally Harmonized System, or GHS, mixtures equation, which can help estimate acute oral toxicity for some pesticide formulations from data on their ingredients.
This is a change in review methods, not a new consumer-safety standard. The announcement does not impose a product ban, announce a recall, change an exposure limit or declare all soaps, detergents, cleaners or pesticides safe or low-risk.
How the surfactant method works
Surfactants are chemicals that help liquids mix, spread or wet surfaces. They are used in consumer products such as soaps, detergents and cleaners, as well as in industrial and workplace settings.
EPA’s August 27 technical memorandum describes an interim approach for certain new chemical substances that uses MucilAir, a three-dimensional human airway epithelial tissue model. EPA exposed the human-derived tissue to five concentrations of each reference chemical for 24 hours and evaluated biomarkers associated with respiratory irritation, including inflammatory signals, cell damage, barrier integrity and cilia activity.
The initial reference chemicals are Triton X-100, a nonionic surfactant, and oleoyl sarcosine, an anionic surfactant. EPA says it will expand the approach as additional data become available for structurally diverse surfactant analogues.
After deriving points of departure from the tissue experiments, EPA used its Multiple-Path Particle Dosimetry, or MPPD, version 2.0 model to estimate human-equivalent concentrations. In plain language, the model helps estimate where inhaled particles may deposit in the respiratory tract under representative particle-size and use scenarios.
EPA’s memorandum says the approach is intended to reduce uncertainty associated with differences between rat and human respiratory systems. It remains an interim method and does not automatically replace every animal study or determine every regulatory decision.
How the pesticide calculation works
The second action concerns the use of the GHS mixtures equation for some pesticide formulations. The equation combines toxicity information for known ingredients to estimate the acute oral toxicity of a finished mixture. That can allow a registrant to ask EPA to replace a traditional acute oral animal study when the formulation is expected to be minimally toxic by the oral route.
The pathway is not a blanket exemption. EPA’s submission materials say registrants must provide formulation details, ingredient data, calculated values and supporting acute-toxicity information. The agency may evaluate the calculation alongside existing animal-study data, and acceptance depends on whether the method fits the product and the evidence is sufficient.
EPA’s strategic-vision materials cite a retrospective analysis of 671 formulations: 620 agrochemical formulations and 51 antimicrobial cleaning products. Across all four EPA acute oral Toxicity Categories, the overall concordance between calculated and observed results was 55%. Concordance rose to 82% for mixtures with predicted LD50 values above 500 milligrams per kilogram and reached 87% for mixtures predicted to fall in acute oral Toxicity Category IV.
Those figures provide validation context for the method. They are not a guarantee that the equation will accurately classify every future pesticide mixture.
Why EPA is moving in this direction
The two approaches fit EPA’s stated goal of eliminating remaining mammalian testing by 2035. The agency says that goal is consistent with its January 2026 recommitment and with the Toxic Substances Control Act’s requirement that EPA promote methods that reduce, refine or replace vertebrate animal testing when they provide information of equivalent or better scientific quality and relevance.
EPA groups these tools under the term new approach methodologies, or NAMs. The category includes human-cell and tissue systems, computer models, read-across methods and calculations based on existing chemical information.
The GHS mixtures equation itself is not new. EPA launched a pilot program in 2016 to evaluate its usefulness for pesticide toxicity assessments, closed the submission period for new data in 2019 and later analyzed the submitted acute oral data. The August 27 announcement places that work within the agency’s current push to expand non-animal methods.
What changes for consumers and workers
Consumers should not expect immediate changes to household-product labels, pesticide instructions or approved uses based on this announcement alone. The agency did not announce a recall, change a product’s legal use or issue a new exposure limit.
Workers and employers should continue following applicable product labels, workplace requirements and safety instructions. Any future effect on workplace controls would depend on the specific chemical, the evidence EPA accepts and the rules or risk assessments governing that use.
Manufacturers and pesticide registrants may gain additional ways to support EPA reviews without commissioning some new animal studies. But those options remain limited by the method’s scope and by EPA’s case-by-case review of submitted evidence.
What to watch next
The next important signals will be EPA technical documents, review decisions and guidance showing whether the surfactant framework expands beyond Triton X-100 and oleoyl sarcosine. For pesticides, watch how often registrants submit GHS-equation calculations and whether EPA accepts them in place of additional acute oral studies for qualifying formulations.
The broader significance is methodological. Selected parts of chemical review are moving toward human-relevant tissue models, digital dosimetry and ingredient-based calculations. The August 27 announcement does not, by itself, change what products consumers may buy or how they must be used.
Sources
Look for updates to this story
Discover more from Interactive News
Subscribe to get the latest posts sent to your email.